High Calcium Risk in CKD Cat Diets Revealed

New Study Reveals Critical Calcium Risk in Some Kidney Diets for Cats

Cats with early-stage chronic kidney disease (CKD) are often fed phosphate-restricted foods to slow disease progression. However, a 2025 study from Oregon State University and Hill’s Pet Nutrition shows the degree of restriction matters. Cats given a diet with very high phosphate restriction developed significant elevations in blood calcium, altering key hormones and increasing their calculated risk for forming calcium oxalate stones. This evidence suggests that for early-stage disease, a more moderate approach may be safer.

Highly Restricted Phosphate Diets Disrupt Calcium Homeostasis

The study, led by Dr. Jennifer Hall at Oregon State University, assigned 18 cats with stage 1 or 2 CKD to one of two veterinary therapeutic diets for 140 days. One diet was moderately phosphate restricted (M-PR; Ca:P ratio 1.2:1). The other was highly phosphate restricted (H-PR; Ca:P ratio 2.0:1). All cats started with normal blood calcium.

By day 28, a clear divergence appeared. Cats on the H-PR diet had higher levels of ionized calcium, a biologically active form, and this difference grew. At the study’s end, the H-PR group’s average ionized calcium was 1.42 mmol/L, significantly above the normal range (1.10–1.30 mmol/L). Their total calcium averaged 11.49 mg/dL, also above normal (8.80–10.00 mg/dL). The M-PR group maintained calcium levels within normal limits.

This hypercalcemia had direct consequences. The kidneys excreted more calcium into the urine, and two separate metrics for calcium oxalate (CaOx) stone formation risk increased sharply for the H-PR group. Their relative supersaturation score and concentration-risk index were far higher, indicating a greater likelihood of developing painful urinary stones—a new problem layered on top of existing kidney disease.

Hormonal Pathways Explain the Mineral Imbalance

The research team measured several hormones to understand why calcium rose. Their findings reveal a cascade of dysregulation caused by the diet’s mineral composition.

Cats on the H-PR diet showed a dramatic ten-fold increase in fibroblast growth factor-23 (FGF-23), a hormone that normally helps the kidneys excrete phosphate. Despite having lower dietary phosphate, their FGF-23 levels soared. Parathyroid hormone (PTH), which raises blood calcium, was suppressed to nearly undetectable levels. Meanwhile, calcitriol, the active form of vitamin D that promotes calcium absorption from the gut, was lower in the H-PR group.

This pattern suggests the high dietary calcium-to-phosphorus ratio itself drove the hypercalcemia. The body’s normal regulatory checkpoints, like PTH, were overridden. The study authors note that sustained high FGF-23 is itself a negative prognostic marker in CKD. While managing phosphorus is a cornerstone of kidney diet therapy, this study demonstrates that an imbalance can create significant secondary issues.

Vitamin E Supplementation Fails to Extend Lifespan

A separate 2024 study from the University of Ljubljana provides another important, if disappointing, data point. Researchers investigated whether adding the antioxidant vitamin E to a commercial renal diet could improve outcomes for cats with CKD.

In this controlled trial, supplementing with vitamin E did not prolong survival time. The study adds to a body of evidence suggesting that single antioxidant supplements may not capture the complex benefits of whole-food antioxidants or balanced therapeutic diets. Managing CKD effectively relies on a multi-faceted approach proven to slow progression, not on isolated nutrient additions without specific evidence. This finding aligns with research in other areas, like feline IBD management, where the source and combination of nutrients matter greatly.

Choosing and Monitoring a Kidney Diet for Your Cat

These studies emphasize that not all “kidney” or “renal” diets are the same. The 2025 study specifically compared two prescription foods, showing that their formulation led to different physiological outcomes. For a cat with early-stage CKD, a diet that maintains a more moderate calcium-to-phosphorus balance may help avoid iatrogenic hypercalcemia and stone risk.

This decision must be made with a veterinarian. They will diagnose the CKD stage through bloodwork, urinalysis, and sometimes blood pressure measurement. It is important to note that the study focused on early-stage (1 and 2) CKD. Nutritional needs can change as disease progresses; a diet that is appropriate for advanced disease may differ. Regular monitoring of blood calcium, phosphorus, and kidney values is essential to catch any imbalances. Pet owners should also be aware of other dietary risks, such as the hidden phosphates in some raw pet foods.

The research has limitations. It involved a small number of colony-housed cats over 20 weeks. Longer-term effects in a more diverse pet cat population are not yet known. However, the hormonal and risk metric changes provide a strong mechanistic warning.

Conclusion

Dietary management for feline CKD is effective but must be precise. New evidence indicates that over-restricting phosphorus without regard for calcium balance can trigger hypercalcemia and increase urinary stone risk. A moderate approach, coupled with consistent veterinary monitoring, appears to offer a safer path for cats in the early stages of kidney disease.

Sources:
https://pubmed.ncbi.nlm.nih.gov/41252663/
https://pubmed.ncbi.nlm.nih.gov/38987749/
https://pubmed.ncbi.nlm.nih.gov/38952053/